ROR2 and melanoma: Research has shown that hypoxia can induce a switch in melanoma cells from a receptor tyrosine kinase-like orphan receptor 1 (ROR1)+ to a more invasive ROR2+ phenotype, which is associated with resistance to BRAF inhibitors.